(1) Controlled-Release PHEN/TPM in Severely Obese Adults (EQUIP) trial (obesity without comorbidities), (2) Controlled-Release Phentermine plus Topiramate Combination in Overweight and Obese Adults (CONQUER) trial (obesity with comorbidities), and (3) SEQUEL (2-year extension of CONQUER), were comprised of 7% of older adult participants across the trials, although the upper age limit was 70 [111,112,113]
reassess for any new symptoms (edema, pericardial effusion signs, unexplained fatigue) Ongoing: Annual metabolic panel if both agents are continued long-term
How much levocarnitine is in each dose of the blend
Book online or call between 8 AM and 10 PM
as such, concluding from this study alone that patients with type 2 diabetes taking GLP-1 drugs are more likely to develop wet AMD is premature
Bestsellers include the Hydration Gel Water Tube, Hypoderma SP1-2GF Serum Cell Repair, Gummy Sheet Mask Madecassoside Sticker and Facial Soap Black Brick